|
⚲
|
| Keyboard |
| Octagon Biotech Opportunities Fund II LP | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0002132995 |
| Sale | 2026-06-24 (175.0 M Offered, 17.8 M Sold) |
| Fund | Private Equity Fund |
| Phone | 2123692829 |
| Address | 654 Madison Avenue, Fl 21 New York, NY 10065 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2026-07-02 (D) |
| Exemption | 506(b), 3(c), 3(c)(7) |
| Minimum | $5,000,000 |
| Remaining | $157,200,000 |
| Duration | One year or less |
| Revenue | Decline to Disclose |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| Dr Ting Jia | Executive Officer | |
| Octagon Capital Advisors LP | Promoter | |
| Octagon Investments GP LLC | Director |
| Comparable Firms | State | AUM |
|---|---|---|
|
Kairos Investment Advisors LLC
✚
|
NY | |
|
Millennium TVP Management Co LLC
✚
|
NY | |
|
Coatue Opportunity Fund II LP
✚
|
NY | |
|
Bishop Rock Capital LP
✚
|
NY | |
|
Biospring Management Partners LP
✚
|
NY | |
|
Soroban Capital Partners LLC
✚
|
NY | |
|
MSREF II Inc
✚
|
NY | |
|
Macellum Management LP
✚
|
NY | |
|
Highbrook Investment Management LP
✚
|
NY | |
|
Aetos Capital Partners Management LLC
✚
|
NY |